Skip to main content


Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Safety of targeting tumor endothelial cell antigens

Fig. 1

Analysis of antibodies against tumor endothelial antigens in three patients treated with ValloVax™. Antibodies against each of the antigens indicated were detected in dilutions of patient serum samples by ELISA and OD 490 readings were compared for pre-immunization, and time points (T1 and T2) following immunization with ValloVax™

Back to article page